logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • China related news
    • Insights
    • Client Press Releases
    • Client Coverage
  • CEO Interviews
  • Clients
    • Public Companies
    • In-depth Analysis
    • Trusted Advisors
      • Mortgage Broker
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • Events
    • Apr 15, 2021 – GCFF Virtual Innovation Event
    • GCFF Conference
    • Past GCFF Events
  • Home
  • Genomics
Filter

Genomics

Categories

Sectors

Locations

Exchange

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Intention to Pay Dividend on Preferred Shares

March 31, 2021

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Debt Settlement

March 25, 2021

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference

February 18, 2021

医疗保健精选——Sesen目标价获上调;Sundial向大麻食品公司Indiva投资$2200万

Healthcare Roundup – Sesen price target raised on prospects for bladder cancer therapy; Sundial makes $22M investment in cannabis edibles company Indiva

February 16, 2021

Life Science

Healthcare Roundup – G1 Therapeutics jumps 16.9% as trilaciclib wins FDA approval; Bionano Genomics shares hit all-time high, spiking nearly 23%

February 12, 2021

Life Science

Healthcare Roundup – Generex announces receipt of $2M for its COVID-19 vaccine development; I-Mab’s cancer therapy greenlighted in China for phase 1 trial

February 10, 2021

Life Science

RepliCel Closes First Tranche of Strategic Investment Commitment

February 10, 2021

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel CEO Provides Corporate Update

February 8, 2021

Life Science

Healthcare Roundup – Omega Health buys 24 facilities for $510M; Align Tech up 13% as analysts view Q4 2020 results favorably

February 4, 2021

Life Science

医疗保健精选--Jazz将通过现金和股票交易收购GW Pharma;Cassava Sciences取得阿尔茨海默病治疗的积极试验数据后股价上涨

Healthcare Roundup – Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B; Anavex gains after favorable data from Cassava Sciences in Alzheimer’s

February 4, 2021

Life Science

医疗保健精选——阿斯利康新冠疫苗获欧洲批准;eHealth宣布获得2.25亿美元战略投资

Healthcare Roundup – AstraZeneca gets European nod for COVID-19 vaccine; eHealth announces $225M strategic investment from H.I.G. capital

January 30, 2021

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement

January 25, 2021

Life Science

Healthcare Roundup – Intuitive Surgical earns mixed reviews from analysts despite earnings beat; Amyris acquires Terasana Brand for offering clean cannabinoid consumer products

January 22, 2021

Life Science

医疗保健精选——Moderna日本早期新冠疫苗试验接种首位参与者;基因编辑公司股价攀升

Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest

January 21, 2021

Life Science

医疗保健精选—以色列和辉瑞公司分享新冠疫苗数据,Grifols公司将试验新冠肺炎的新型免疫球蛋白疗法

Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September;Grifols to trial new immunoglobulin therapy against COVID-19

January 18, 2021

Life Science

Healthcare Roundup – Norway says deaths after COVID-19 jab may be from side effects, Sorrento could nearly quadruple in value: analyst

January 15, 2021

Life Science

医疗精选——分析师看好强生单剂量新冠疫苗;礼来在研阿尔茨海默症治疗药物显示疗效,股价上涨20%

Healthcare Roundup – JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts; Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer’s study

January 12, 2021

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis

December 22, 2020

Life Science

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Terms of Use
  • Content Partner
  • Chinese Investor Relations Outreach Program
  • About Us
  • Contact Us

© 2021 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada